课题基金 / 基金详情

Request for Purchase of High-Performance MRI System for in-vivo Rodent Imaging

Request for Purchase of High-Performance MRI System for in-vivo Rodent Imaging
请求购买用于啮齿类动物体内成像的高性能 MRI 系统
批准号:
8948335
负责人:
Anthony J. BAKER
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-04-01 至 2015-09-30

项目摘要

项目成果

Anthony J. BAKER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): This proposal requests funding for a Compact, High-Performance Magnetic Resonance Imaging (MRI) System for in-vivo Rodent Imaging. Rodents are the most commonly used experimental animals in biomedical research. However, the VA San Francisco does not have rodent MRI imaging capability. Currently, projects that need to monitor internal structures and physiological functions within living rats or mice are hampered by the lack of a high-resolution rodent MRI system. Therefore, acquisition of a rodent MRI system will fulfill a critical need for multiple research projects at the VA SF. Eight major users and four minor users compose the first cohort of investigators who have expressed a critical need for this instrument. These investigators perform research in diverse research areas of Cancer, Cardiovascular, Musculoskeletal, Nephrology and Neuroscience. A high performance rodent MRI system will make possible precise measurements of multiple in- vivo parameters. For example, monitoring of: * Tumor location, mass, and shape * Ischemic regions in mouse brain and nerves * Cardiac structure, ventricular volumes and contractile function of all 4 chambers of the heart and the presence of ischemic injury * Skeletal muscle mass and ischemic injury * Integrity of joints, tendons and bone. Vascular imaging. * Kidney structure and damage Therefore, a rodent MRI system will aid the research of multiple projects in several areas of investigation that are critically relevan to veteran's health. These projects involve exploration of new therapies to treat brain injury, cancer, heart disease, musculoskeletal injury, orthopedic diseases, and renal failure. These diseases are highly relevant to the veteran patient population. The instrument requested is a Bruker ICON MRI system. This is a relatively low priced MRI system that has two innovative and significant technical advantages: First, the Bruker ICON MRI system uses a compact permanent magnet rather than a traditional superconducting MRI magnet. Therefore, the permanent magnet does not require cooling with cryogens. Accordingly, the significant costs and maintenance associated with a traditional superconducting magnet are not required. This system has no ongoing maintenance requirements. It does not contain parts that need regular replacement or replenishing. Second, the Bruker ICON MRI system uses a self-shielded permanent magnet, and therefore does not require additional external shielding. The magnet has negligible magnetic fringe fields outside of the magnet. Thus, the compact magnet can be housed in regular laboratory space and does not require a separate shielded location. Furthermore, the Bruker ICON system does not require MRI safety protocols that must be used with a traditional MRI system. In summary, acquisition of a rodent MRI system will address a significant research need, and will greatly aid many research projects in multiple fields covering diseases that are highly significant to the veteran patient population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multiscale mechanobiology of right ventricular failure
  • 批准号:
    10616981
  • 项目类别:
  • 资助金额:
    $7.62万
  • 财政年份:
    2020
  • 负责人:
    Anthony J. BAKER
  • 依托单位:
Multiscale mechanobiology of right ventricular failure
  • 批准号:
    10472032
  • 项目类别:
  • 资助金额:
    $71.18万
  • 财政年份:
    2020
  • 负责人:
    Anthony J. BAKER
  • 依托单位:
Multiscale mechanobiology of right ventricular failure
  • 批准号:
    10657570
  • 项目类别:
  • 资助金额:
    $69.65万
  • 财政年份:
    2020
  • 负责人:
    Anthony J. BAKER
  • 依托单位:
Multiscale mechanobiology of right ventricular failure
  • 批准号:
    10402165
  • 项目类别:
  • 资助金额:
    $71.41万
  • 财政年份:
    2020
  • 负责人:
    Anthony J. BAKER
  • 依托单位:
海外基金